LEADER 02019oas  2200793 a 450 
001 9910735299003321
005 20260218112215.0
035   $a(DE-599)ZDB2703046-5
035   $a(OCoLC)794005707
035   $a(CONSER)  2012202883
035   $a(CKB)2560000000083811
035   $a(DE-599)2703046-5
035   $a(EXLCZ)992560000000083811
100   $a20120521a20139999  oy         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExpert opinion on orphan drugs
210  1$a[London] :$cInforma Healthcare,$d2013-
210 31$a[Abingdon, UK] :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$a2167-8707 
606   $aRare diseases$vPeriodicals
606   $aOrphan drugs$vPeriodicals
606   $aChemotherapy$vPeriodicals
606   $aOrphan Drug Production
606   $aRare Diseases
606   $aChemotherapy$2fast$3(OCoLC)fst00853595
606   $aOrphan drugs$2fast$3(OCoLC)fst01048416
606   $aRare diseases$2fast$3(OCoLC)fst01090123
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aRare diseases
615  0$aOrphan drugs
615  0$aChemotherapy
615 12$aOrphan Drug Production.
615 22$aRare Diseases.
615  7$aChemotherapy.
615  7$aOrphan drugs.
615  7$aRare diseases.
676   $a615
801  0$bDLC
801  1$bDLC
801  2$bNLM
801  2$bDLC
801  2$bUWW
801  2$bOCLCO
801  2$bOCLCF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCO
801  2$bCUS
801  2$bOCLCQ
801  2$bTXA
801  2$bDLC
801  2$bAU@
801  2$bOCLCO
801  2$bOCLCA
801  2$bOCLCQ
801  2$bUEJ
801  2$bOCLCL
906   $aJOURNAL
912   $a9910735299003321
996   $aExpert opinion on orphan drugs$93420082
997   $aUNINA